Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Trauma-Related Major Depressive Disorder: Randomized Controlled Trial
Phase: PHASE3 | Sponsor: Khyber Medical University Peshawar | Compound: Psilocybin
- Status
- recruiting
- Institution
- Khyber Medical University Peshawar
- Start date
- 2026-04-01
- End date
- 2027-11-22
- Registry ID
- NCT07703722
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.